BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Duarte MC, Lage LM, Lage DP, Martins VT, Carvalho AM, Roatt BM, Menezes-Souza D, Tavares CA, Alves RJ, Barichello JM, Coelho EA. Treatment of murine visceral leishmaniasis using an 8-hydroxyquinoline-containing polymeric micelle system. Parasitol Int 2016;65:728-36. [PMID: 27425599 DOI: 10.1016/j.parint.2016.07.005] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Sousa JKT, Antinarelli LMR, Mendonça DVC, Lage DP, Tavares GSV, Dias DS, Ribeiro PAF, Ludolf F, Coelho VTS, Oliveira-da-Silva JA, Perin L, Oliveira BA, Alvarenga DF, Chávez-Fumagalli MA, Brandão GC, Nobre V, Pereira GR, Coimbra ES, Coelho EAF. A chloroquinoline derivate presents effective in vitro and in vivo antileishmanial activity against Leishmania species that cause tegumentary and visceral leishmaniasis. Parasitol Int 2019;73:101966. [PMID: 31362122 DOI: 10.1016/j.parint.2019.101966] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
2 Savić-gajić IM, Savić IM. Drug design strategies with metal-hydroxyquinoline complexes. Expert Opinion on Drug Discovery 2020;15:383-90. [DOI: 10.1080/17460441.2020.1702964] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Cherdtrakulkiat R, Lawung R, Nabu S, Tantimavanich S, Sinthupoom N, Prachayasittikul S, Prachayasittikul V. Nitroxoline: a potent antimicrobial agent against multidrug resistant Enterobacteriaceae. EXCLI J 2019;18:445-53. [PMID: 31423123 DOI: 10.17179/excli2019-1378] [Reference Citation Analysis]
4 Toscanini MA, Limeres MJ, Garrido AV, Cagel M, Bernabeu E, Moretton MA, Chiappetta DA, Cuestas ML. Polymeric micelles and nanomedicines: Shaping the future of next generation therapeutic strategies for infectious diseases. Journal of Drug Delivery Science and Technology 2021;66:102927. [DOI: 10.1016/j.jddst.2021.102927] [Reference Citation Analysis]
5 Khatonier R, Ahmed G, Sarmah P, Narain K, Khan AM. Immunomodulatory role of Th17 pathway in experimental visceral leishmaniasis. Immunobiology 2021;226:152148. [PMID: 34773853 DOI: 10.1016/j.imbio.2021.152148] [Reference Citation Analysis]
6 Tavares GS, Mendonça DV, Miyazaki CK, Lage DP, Soyer TG, Carvalho LM, Ottoni FM, Dias DS, Ribeiro PA, Antinarelli LM, Ludolf F, Duarte MC, Coimbra ES, Chávez-fumagalli MA, Roatt BM, Menezes-souza D, Barichello JM, Alves RJ, Coelho EA. A Pluronic® F127-based polymeric micelle system containing an antileishmanial molecule is immunotherapeutic and effective in the treatment against Leishmania amazonensis infection. Parasitology International 2019;68:63-72. [DOI: 10.1016/j.parint.2018.10.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
7 Reis TAR, Oliveira-da-Silva JA, Tavares GSV, Mendonça DVC, Freitas CS, Costa RR, Lage DP, Martins VT, Machado AS, Ramos FF, Silva AM, Ludolf F, Antinarelli LMR, Brito RCF, Chávez-Fumagalli MA, Humbert MV, Roatt BM, Coimbra ES, Coelho EAF. Ivermectin presents effective and selective antileishmanial activity in vitro and in vivo against Leishmania infantum and is therapeutic against visceral leishmaniasis. Exp Parasitol 2021;221:108059. [PMID: 33338468 DOI: 10.1016/j.exppara.2020.108059] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Mendonça DV, Tavares GS, Lage DP, Soyer TG, Carvalho LM, Dias DS, Ribeiro PA, Ottoni FM, Antinarelli LM, Vale DL, Ludolf F, Duarte MC, Coimbra ES, Chávez-fumagalli MA, Roatt BM, Menezes-souza D, Barichello JM, Alves RJ, Coelho EA. In vivo antileishmanial efficacy of a naphthoquinone derivate incorporated into a Pluronic® F127-based polymeric micelle system against Leishmania amazonensis infection. Biomedicine & Pharmacotherapy 2019;109:779-87. [DOI: 10.1016/j.biopha.2018.10.143] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
9 Mendonça DVC, Martins VT, Lage DP, Dias DS, Ribeiro PAF, Carvalho AMRS, Dias ALT, Miyazaki CK, Menezes-Souza D, Roatt BM, Tavares CAP, Barichello JM, Duarte MC, Coelho EAF. Comparing the therapeutic efficacy of different amphotericin B-carrying delivery systems against visceral leishmaniasis. Exp Parasitol 2018;186:24-35. [PMID: 29448040 DOI: 10.1016/j.exppara.2018.02.003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
10 Mendonça DVC, Tavares GSV, Pereira IAG, Oliveira-da-Silva JA, Ramos FF, Lage DP, Machado AS, Carvalho LM, Reis TAR, Carvalho AMRS, Ottoni FM, Ludolf F, Freitas CS, Martins VT, Chávez-Fumagalli MA, Duarte MC, Humbert MV, Roatt BM, Menezes-Souza D, Alves RJ, Coelho EAF. Flau-A, a naphthoquinone derivative, is a promising therapeutic candidate against visceral leishmaniasis: A preliminary study. Exp Parasitol 2021;:108205. [PMID: 34968460 DOI: 10.1016/j.exppara.2021.108205] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
11 Tavares GSV, Mendonça DVC, Pereira IAG, Oliveira-da-Silva JA, Ramos FF, Lage DP, Machado AS, Carvalho LM, Reis TAR, Perin L, Carvalho AMRS, Ottoni FM, Ludolf F, Freitas CS, Bandeira RS, Silva AM, Chávez-Fumagalli MA, Duarte MC, Menezes-Souza D, Alves RJ, Roatt BM, Coelho EAF. A clioquinol-containing Pluronic® F127 polymeric micelle system is effective in the treatment of visceral leishmaniasis in a murine model. Parasite 2020;27:29. [PMID: 32351209 DOI: 10.1051/parasite/2020027] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
12 Freitas CS, Lage DP, Oliveira-da-Silva JA, Costa RR, Mendonça DVC, Martins VT, Reis TAR, Antinarelli LMR, Machado AS, Tavares GSV, Ramos FF, Brito RCF, Ludolf F, Chávez-Fumagalli MA, Roatt BM, Ramos GS, Munkert J, Ottoni FM, Campana PRV, Duarte MC, Gonçalves DU, Coimbra ES, Braga FC, Pádua RM, Coelho EAF. In vitro and in vivo antileishmanial activity of β-acetyl-digitoxin, a cardenolide of Digitalis lanata potentially useful to treat visceral leishmaniasis. Parasite 2021;28:38. [PMID: 33851916 DOI: 10.1051/parasite/2021036] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Costa RR, Oliveira-da-Silva JA, Reis TAR, Tavares GSV, Mendonça DVC, Freitas CS, Lage DP, Martins VT, Antinarelli LMR, Machado AS, Bandeira RS, Ludolf F, Santos TTO, Brito RCF, Humbert MV, Menezes-Souza D, Duarte MC, Chávez-Fumagalli MA, Roatt BM, Coimbra ES, Coelho EAF. Acarbose presents in vitro and in vivo antileishmanial activity against Leishmania infantum and is a promising therapeutic candidate against visceral leishmaniasis. Med Microbiol Immunol 2021;210:133-47. [PMID: 33870453 DOI: 10.1007/s00430-021-00707-4] [Reference Citation Analysis]
14 Tavares GSV, Mendonça DVC, Lage DP, Granato JDT, Ottoni FM, Ludolf F, Chávez-Fumagalli MA, Duarte MC, Tavares CAP, Alves RJ, Coimbra ES, Coelho EAF. Antileishmanial Activity, Cytotoxicity and Mechanism of Action of Clioquinol Against Leishmania infantum and Leishmania amazonensis Species. Basic Clin Pharmacol Toxicol 2018;123:236-46. [PMID: 29481714 DOI: 10.1111/bcpt.12990] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 5.5] [Reference Citation Analysis]
15 Freitas CS, Oliveira-da-Silva JA, Lage DP, Costa RR, Mendonça DVC, Martins VT, Reis TAR, Antinarelli LMR, Machado AS, Tavares GSV, Ramos FF, Coelho VTS, Brito RCF, Ludolf F, Chávez-Fumagalli MA, Roatt BM, Ramos GS, Munkert J, Ottoni FM, Campana PRV, Humbert MV, Coimbra ES, Braga FC, Pádua RM, Coelho EAF. Digitoxigenin presents an effective and selective antileishmanial action against Leishmania infantum and is a potential therapeutic agent for visceral leishmaniasis. Parasitol Res 2021;120:321-35. [PMID: 33191446 DOI: 10.1007/s00436-020-06971-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Sharma L, Dhiman M, Singh A, Sharma MM. Green Approach: ''A Forwarding Step for Curing Leishmaniasis-A Neglected Tropical Disease''. Front Mol Biosci 2021;8:655584. [PMID: 34124148 DOI: 10.3389/fmolb.2021.655584] [Reference Citation Analysis]
17 Tavares GSV, Mendonça DVC, Lage DP, Antinarelli LMR, Soyer TG, Senna AJS, Matos GF, Dias DS, Ribeiro PAF, Batista JPT, Poletto JM, Brandão GC, Chávez-Fumagalli MA, Pereira GR, Coimbra ES, Coelho EAF. In vitro and in vivo antileishmanial activity of a fluoroquinoline derivate against Leishmania infantum and Leishmania amazonensis species. Acta Trop 2019;191:29-37. [PMID: 30586571 DOI: 10.1016/j.actatropica.2018.12.036] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
18 Varma DM, Redding EA, Bachelder EM, Ainslie KM. Nano- and Microformulations to Advance Therapies for Visceral Leishmaniasis. ACS Biomater Sci Eng 2021;7:1725-41. [DOI: 10.1021/acsbiomaterials.0c01132] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
19 Wagner V, Minguez-menendez A, Pena J, Fernández-prada C. Innovative Solutions for the Control of Leishmaniases: Nanoscale Drug Delivery Systems. CPD 2019;25:1582-92. [DOI: 10.2174/1381612825666190621154552] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
20 Oyama J, Lera-Nonose DSSL, Ramos-Milaré ÁCFH, Padilha Ferreira FB, de Freitas CF, Caetano W, Hioka N, Silveira TGV, Lonardoni MVC. Potential of Pluronics® P-123 and F-127 as nanocarriers of anti-Leishmania chemotherapy. Acta Trop 2019;192:11-21. [PMID: 30659806 DOI: 10.1016/j.actatropica.2019.01.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
21 Pereira IAG, Mendonça DVC, Tavares GSV, Lage DP, Ramos FF, Oliveira-da-Silva JA, Antinarelli LMR, Machado AS, Carvalho LM, Carvalho AMRS, Salustiano IV, Reis TAR, Bandeira RS, Silva AM, Martins VT, Chávez-Fumagalli MA, Humbert MV, Roatt BM, Duarte MC, Menezes-Souza D, Coimbra ES, Leite JPV, Coelho EAF, Gonçalves DU. Parasitological and immunological evaluation of a novel chemotherapeutic agent against visceral leishmaniasis. Parasite Immunol 2020;42:e12784. [PMID: 32772379 DOI: 10.1111/pim.12784] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Mendonça DVC, Lage DP, Calixto SL, Ottoni FM, Tavares GSV, Ludolf F, Chávez-Fumagalli MA, Schneider MS, Duarte MC, Tavares CAP, Alves RJ, Coimbra ES, Coelho EAF. Antileishmanial activity of a naphthoquinone derivate against promastigote and amastigote stages of Leishmania infantum and Leishmania amazonensis and its mechanism of action against L. amazonensis species. Parasitol Res 2018;117:391-403. [PMID: 29248978 DOI: 10.1007/s00436-017-5713-6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
23 Kammona O, Tsanaktsidou E. Nanotechnology-aided diagnosis, treatment and prevention of leishmaniasis. Int J Pharm 2021;605:120761. [PMID: 34081999 DOI: 10.1016/j.ijpharm.2021.120761] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
24 Gondim BL, Oshiro-júnior JA, Fernanandes FH, Nóbrega FP, Castellano LR, Medeiros AC. Plant Extracts Loaded in Nanostructured Drug Delivery Systems for Treating Parasitic and Antimicrobial Diseases. CPD 2019;25:1604-15. [DOI: 10.2174/1381612825666190628153755] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
25 Volpedo G, Costa L, Ryan N, Halsey G, Satoskar A, Oghumu S. Nanoparticulate drug delivery systems for the treatment of neglected tropical protozoan diseases. J Venom Anim Toxins Incl Trop Dis 2019;25:e144118. [PMID: 31130996 DOI: 10.1590/1678-9199-JVATITD-1441-18] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 6.3] [Reference Citation Analysis]
26 Lage DP, Ribeiro PAF, Dias DS, Mendonça DVC, Ramos FF, Carvalho LM, Steiner BT, Tavares GSV, Martins VT, Machado AS, Oliveira-da-Silva JA, Santos TTO, Freitas CS, Oliveira JS, Roatt BM, Machado-de-Ávila RA, Humbert MV, Christodoulides M, Coelho EAF. Liposomal Formulation of ChimeraT, a Multiple T-Cell Epitope-Containing Recombinant Protein, Is a Candidate Vaccine for Human Visceral Leishmaniasis. Vaccines (Basel) 2020;8:E289. [PMID: 32526867 DOI: 10.3390/vaccines8020289] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
27 Bruni N, Stella B, Giraudo L, Della Pepa C, Gastaldi D, Dosio F. Nanostructured delivery systems with improved leishmanicidal activity: a critical review. Int J Nanomedicine 2017;12:5289-311. [PMID: 28794624 DOI: 10.2147/IJN.S140363] [Cited by in Crossref: 48] [Cited by in F6Publishing: 15] [Article Influence: 9.6] [Reference Citation Analysis]